HANDOK Inc. (002390.KS)
002390.KS Stock Price Chart
Explore HANDOK Inc. interactive price chart. Choose custom timeframes to analyze 002390.KS price movements and trends.
002390.KS Company Profile
Discover essential business fundamentals and corporate details for HANDOK Inc. (002390.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
4 Jan 2000
Employees
939.00
Website
https://www.handok.co.krCEO
Young-Jin Kim
Description
Handok Inc. operates as an integrated pharmaceutical company. The company provides ETC and OTC drugs, medical devices, and in-vitro diagnostics instruments and devices. It focuses on various therapeutic areas, such as oncology, diabetes and metabolic disorders, CNS orphan diseases, eye disorders, and other disease areas. The company also offers healthcare products comprising food supplements under the NatureSet and Culturelle brands; food and beverages; and medical nutrition products. Handok Inc. has a strategic collaboration agreement with AUM Biosciences Pte. Ltd. and CMG Pharmaceutical Co. Ltd. for the development, manufacturing, and commercialization of CHC2014, a pan-TRK inhibitor for cancer treatment. The company was formerly known as Handok Pharmaceuticals Co., Ltd and changed its name to Handok Inc. in July 2013. Handok Inc. was founded in 1954 and is based in Seoul, South Korea.
002390.KS Financial Timeline
Browse a chronological timeline of HANDOK Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 Apr 2026
Upcoming earnings on 3 Feb 2026
Upcoming earnings on 29 Oct 2025
Earnings released on 31 Jul 2025
Earnings released on 15 May 2025
EPS came in at -₩558.00 , while revenue for the quarter reached ₩119.87B .
Dividend declared on 27 Feb 2025
A dividend of ₩200.00 per share was announced, adjusted to ₩200.00. The dividend was paid on 18 Apr 2025.
Earnings released on 5 Feb 2025
EPS came in at -₩2.43K , while revenue for the quarter reached ₩121.28B .
Earnings released on 31 Oct 2024
EPS came in at -₩240.71 , while revenue for the quarter reached ₩129.04B .
Earnings released on 2 Aug 2024
EPS came in at -₩935.93 , while revenue for the quarter reached ₩128.25B .
Earnings released on 15 May 2024
EPS came in at -₩163.56 , while revenue for the quarter reached ₩128.78B .
Earnings released on 6 Feb 2024
EPS came in at -₩1.11K , while revenue for the quarter reached ₩126.59B .
Dividend declared on 27 Dec 2023
A dividend of ₩300.00 per share was announced, adjusted to ₩300.00. The dividend was paid on 19 Apr 2024.
Earnings released on 2 Nov 2023
EPS came in at -₩223.17 , while revenue for the quarter reached ₩127.23B .
Earnings released on 11 Aug 2023
EPS came in at -₩441.97 , while revenue for the quarter reached ₩140.55B .
Earnings released on 12 May 2023
EPS came in at -₩319.43 , while revenue for the quarter reached ₩128.37B .
Earnings released on 9 Feb 2023
EPS came in at ₩573.05 , while revenue for the quarter reached ₩136.02B .
Dividend declared on 28 Dec 2022
A dividend of ₩400.00 per share was announced, adjusted to ₩400.00. The dividend was paid on 21 Apr 2023.
Earnings released on 27 Oct 2022
EPS came in at ₩290.00 , while revenue for the quarter reached ₩148.57B .
Earnings released on 28 Jul 2022
EPS came in at -₩114.26 , while revenue for the quarter reached ₩132.08B .
Earnings released on 28 Apr 2022
EPS came in at ₩24.97 , while revenue for the quarter reached ₩127.08B .
Earnings released on 13 Mar 2022
EPS came in at ₩40.40 , while revenue for the quarter reached ₩139.81B , beating expectations by +4.10%.
Dividend declared on 29 Dec 2021
A dividend of ₩350.00 per share was announced, adjusted to ₩350.00. The dividend was paid on 22 Apr 2022.
Earnings released on 30 Oct 2021
EPS came in at -₩155.00 , while revenue for the quarter reached ₩134.94B , beating expectations by +0.70%.
Earnings released on 14 Aug 2021
EPS came in at ₩216.00 , while revenue for the quarter reached ₩123.85B .
Earnings released on 14 May 2021
EPS came in at ₩138.00 , while revenue for the quarter reached ₩119.05B .
Earnings released on 31 Dec 2020
EPS came in at ₩891.05 , while revenue for the quarter reached ₩131.85B , beating expectations by +0.65%.
Dividend declared on 29 Dec 2020
A dividend of ₩300.00 per share was announced, adjusted to ₩300.00. The dividend was paid on 23 Apr 2021.
Earnings released on 30 Sept 2020
EPS came in at ₩1.04K , while revenue for the quarter reached ₩133.21B , beating expectations by +1.53%.
002390.KS Stock Performance
Access detailed 002390.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.